Version 1
: Received: 10 April 2020 / Approved: 12 April 2020 / Online: 12 April 2020 (04:30:07 CEST)
Version 2
: Received: 14 April 2020 / Approved: 15 April 2020 / Online: 15 April 2020 (08:25:18 CEST)
How to cite:
Haj Bloukh, S.; Shaikh, A.; Pathan, H.M.; Edis, Z. Prevalence of COVID-19: A Look behind the Scenes from the UAE and India. Preprints2020, 2020040179. https://doi.org/10.20944/preprints202004.0179.v1
Haj Bloukh, S.; Shaikh, A.; Pathan, H.M.; Edis, Z. Prevalence of COVID-19: A Look behind the Scenes from the UAE and India. Preprints 2020, 2020040179. https://doi.org/10.20944/preprints202004.0179.v1
Haj Bloukh, S.; Shaikh, A.; Pathan, H.M.; Edis, Z. Prevalence of COVID-19: A Look behind the Scenes from the UAE and India. Preprints2020, 2020040179. https://doi.org/10.20944/preprints202004.0179.v1
APA Style
Haj Bloukh, S., Shaikh, A., Pathan, H.M., & Edis, Z. (2020). Prevalence of COVID-19: A Look behind the Scenes from the UAE and India. Preprints. https://doi.org/10.20944/preprints202004.0179.v1
Chicago/Turabian Style
Haj Bloukh, S., Habib M. Pathan and Zehra Edis. 2020 "Prevalence of COVID-19: A Look behind the Scenes from the UAE and India" Preprints. https://doi.org/10.20944/preprints202004.0179.v1
Abstract
Mankind faces a coronavirus pandemic originating from a seafood market in Wuhan, China since December 2019. The pathogen was named novel coronavirus (n-CoV) and bats are the identified key reservoir. The coronavirus disease 2019 (COVID-19) quickly spread over China across the globe, turned into a pandemic with exponentially increasing numbers of cases and significant mortality rate. China reacted with lockdowns and strict control measurements to prevent spreading the virus. The treatment of severe cases was hampered by lack of specific vaccines. Vaccine-development and production is a painstaking process and can only be enforced by international cooperation. Different supportive treatment options surfaced due to combinations of antiviral agents with antibiotic drugs. Elderly, male, immune-suppressed patients with co-morbidities showed a high mortality rate. Health literacy, strong immune system, adequate serum 25-hydroxyvitamin D (25(OH)D) concentrations and healthy life style choices can support fast recovery. Antibiotic resistance needs to be addressed by development of new generation antimicrobials against nosocomial infections in preparation for future outbreaks. Plant-biosynthesis of nanomaterials and antiseptics may help in prevention and recovery rate. Prevalence of COVID-19 maybe inversely related to BCG vaccination, endemicity of malaria, humidy and temperature but directly with latitude. Recommendations to prevent the spread of COVID-19 should be followed strictly.
Keywords
COVID-19; SARS-CoV-2; human coronavirus; control; vitamin D; antibiotic resistance; antimicrobial agents; BCG; malaria; climate; latitude
Subject
Biology and Life Sciences, Virology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
